3 Canadian Stocks With Russian Exposure

Will investors feel Russian pain from these 3 companies with exposure to the country?

| More on:
The Motley Fool

One of the biggest news stories this year has been the situation in Crimea. It may seem far away, but here in Canada, we aren’t totally immune to these events. Our government has condemned the Russian actions, joining in international sanctions against the country. Russia responded by banning 13 Canadian lawmakers from entering the country, all with Ukrainian ties.

But that’s not the only way Canada has been affected. In this age of worldwide finance, there are Canadian companies with substantial operations in Russia. Here are three large caps with Russian exposure that may be in your portfolio.

Kinross Gold

Shares in Kinross Gold (TSX: K)(NYSE: KGC) are down close to 20% since the crisis started, and the company has recently started to encourage Steven Harper’s government to ensure Canadian companies operating in Russia won’t be hurt by the sanctions. Harper’s response was essentially “too bad.”

Kinross is the Canadian company most exposed to Russia, as approximately 27% of the company’s production is located within the country. While the company hasn’t seen any changes so far in operations, it is obviously encouraging both governments to tone down the rhetoric. Kinross is somewhat being helped by a lower Russian Ruble, which decreases costs in the country.

Kinross’s biggest fear is that the Russian government could seize mines if relations between the two nations get too strained. Operating in Russia during good times has obvious political risk, and it only gets worse during times of international tension. So far it has been business as usual for Kinross’s operations in Russia, but it’s still something investors should keep in the back of their minds.


Canadian aerospace giant Bombardier (TSX: BBD.B) has a joint project with Russian train maker that brings in about $240 million per year in revenue, which continues to run smoothly. The company is also in talks with a company near Moscow to partner with it on assembling C-Series aircraft. These talks have slowed since the onset of tensions, and likely won’t happen unless things get better between the two nations.

Valeant Pharmaceuticals

Canadian biotech company Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX) does more than $400 million per year in sales in Russia, and it hasn’t really seen those sales affected materially. Company spokesperson Laurie Little said, “so far the only impact we feel in Russia is currency movement, which could continue to fluctuate. Currently it is business as usual for Valeant.” Considering Valeant had $5.8 billion worth of total sales in 2013, don’t look for Russian currency fluctuations to have a huge impact on the bottom line.

Foolish bottom line

Shareholders in Kinross have reason to be nervous about Russian operations, especially if Russia decides to continue with its imperialistic ambitions in the region. At this point, there’s little risk in any material changes in Canadian business in the region, but investors should keep one eye on the news coming out of the region.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any stock mentioned in this article.

More on Investing

rail train
Stocks for Beginners

This Homegrown Railroad Is a No-Brainer Value Stock

CNR (TSX:CNR) stock continues to be the best of the best in terms of the future performance in railway, with…

Read more »

Business man on stock market financial trade indicator background.
Tech Stocks

This Growth Stock Is Down 26%: Buy, Sell, or Hold?

While many growth stocks took to the sky after the December 2023 earnings, this one growth stock fell 26%. Should…

Read more »

Man data analyze
Dividend Stocks

1 Magnificent S&P 500 Dividend Stock Down 39% to Buy and Hold Forever

NextEra Energy is among the largest utility companies in the world, which has delivered inflation-beating returns in the last 20…

Read more »

stock research, analyze data
Dividend Stocks

2 Magnificent Stocks to Buy That Are Near 52-Week Lows

Do you want to add some magnificent stocks to your portfolio? Here are two discounted options that you will regret…

Read more »

four people hold happy emoji masks
Metals and Mining Stocks

Got $200? 2 Lithium Stocks to Buy and Hold Forever

Lithium stocks may not be in the headlines like chip stocks, but they have just as much growth potential over…

Read more »

Dividend Stocks

Don’t Miss This Once-in-a-Decade Chance to Lock in a 9% Dividend Yield

Is your passive income portfolio earning a decent dividend yield? Here is an opportunity to boost your portfolio with a…

Read more »

Senior Couple Walking With Pet Bulldog In Countryside

3 TSX Stocks That Could Help Make You Rich by Retirement

TSX stocks like goeasy have the potential to outperform the broader equity markets by a wide margin and deliver solid…

Read more »

Dividend Stocks

If You Invested $10,000 in BCE Stock in 2010, This Is How Much You Would Have Today

There are many ways to earn money from the same stock. Here are three ways to invest $10,000 in BCE…

Read more »